NCT05494346View on ClinicalTrials.gov

"Safety and Performance Assessment of the Decongestant Seawater Spray Pocket Valve Enriched With Essential Oils in Patients With Acute Rhinitis Associated With Nasal Obstruction: DEVALPO"

NARecruitingINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

June 23, 2023

Primary Completion Date

April 18, 2026

Study Completion Date

June 30, 2026

Conditions
Acute RhinitisNasal ObstructionRhinosinusitisRhinopharyngitisAllergic Rhinitis
Interventions
DEVICE

Measurement of peak nasal flow.

Peak nasal flow measurements will be performed before and after the first use of the spray at D0, as well as after the use of the spray at the medical office at D3 (only for arm A).

Trial Locations (5)

14000

RECRUITING

Cabinet Médical Caen, Caen

14550

RECRUITING

Cabinet Médical, Blainville-sur-Orne

49330

RECRUITING

MSP du Haut Anjou, Châteauneuf-sur-Sarthe

67000

COMPLETED

ALYATEC, Strasbourg

76700

WITHDRAWN

Cabinet Médical Gainneville, Gainneville

Sponsors
All Listed Sponsors
collaborator

EVAMED

OTHER

lead

Laboratoires Gilbert

INDUSTRY

NCT05494346 - "Safety and Performance Assessment of the Decongestant Seawater Spray Pocket Valve Enriched With Essential Oils in Patients With Acute Rhinitis Associated With Nasal Obstruction: DEVALPO" | Biotech Hunter | Biotech Hunter